1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine

Metabolite details

Identifier

BYSIMVBIJVBVPA-RRHRGVEJSA-N

InChI Key

BYSIMVBIJVBVPA-RRHRGVEJSA-N

IUPAC name

(2R)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine

INN name

—

Synonym

Phosphatidylcholine(18:0/16:0)

ChEBI

CHEBI:75026

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity

Observed in differential profiles

• Wild_type_vs_hfq
• Wild_type_vs_hfq
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Healthy_Control_vs_Osteoarticular_Tuberculosis
• Control_vs_Palmitate